Delivery Order SPE2DB20D1109-SPE2DB25FP77A
- Not listed
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,659.03 to AmerisourceBergen Drug Corp for the supply of Noritate 1% Cream in 60-gram units. The contract, executed on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Noritate 1% cream, a pharmaceutical product, with a total value of $3,296.86 and a completion date of March 21, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,652.78 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of NORITATE 1% cream, a pharmaceutical product, with a completion date of July 22, 2024. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,010.20 delivery order is for the supply of Noritate 1% Cream, a pharmaceutical product, with a period of performance through May 13, 2024. Amerisourcebergen Drug Corp holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,571.83 for the procurement of Noritate 1% Cream, a medical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,564.32 firm fixed-price delivery order contract is for the supply of Noritate 1% Cream, a topical medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Noritate 1% Cream, a pharmaceutical product, and has a ceiling value of $3,367.07. It is a firm fixed-price contract with a completion date of February 3, 2025. The contract was awarded on January 31, 2025 and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.74 Firm Fixed Price delivery order is for the supply of "NORITATE 1% CREAM 60GM" and has an ultimate completion date of November 21, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with ID SPE2DB24D3015|SPE2DB24FFWYL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,315.52 firm fixed-price delivery order is for the supply of NORITATE 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $3,917.12 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561313627 NORITATE 1% CREAM 60GM. The place of performance is Conshohocken, Pennsylvania. The period of performance is from June 21, 2023 through June 22, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring and...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP77ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Noritate 1% Cream in 60-gram units. This firm fixed-price delivery order, valued at $20,038.69, is scheduled for completion by September 17, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal medical supply chain for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains and delivery scales, positioning it as a critical vendor within the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 9/16/25 |